4
Changes in Ownership
Acurx Pharmaceuticals, Inc. Filed Acc 0001104659-25-010181
Options or other derivatives
- Chief Financial Officer acquired 145,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Shawah Robert G. Chief Financial Officer | 2025-02-05 | Grant or award · Stock Option | +145,500 | 145,500 | D | ||
Loading xslF345X05/tm255798-3_4seq1.xml…